Co-Authors
This is a "connection" page, showing publications co-authored by Raymund Razonable and John O'Horo.
Connection Strength
0.528
-
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
Score: 0.243
-
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618.
Score: 0.230
-
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife. 2020 07 07; 9.
Score: 0.056